Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Show: All - Companies - Funds
Results 1 - 23 of about 9 companies and 14 funds for Gene Douglas�
Company Exchange Symbol Last price Quote change Market cap
Qiagen NV NASDAQ QGEN 23.54 -0.19 (-0.80%) 5.64B
QIAGEN NV, (QIAGEN) is a holding company, which provides sample and assay technologies. The consumable products such as sample and assay kits and automated ...
GenVec Inc NASDAQ GNVC 1.99 +0.06 (3.11%) 34.37M
GenVec, Inc. develops gene-based pharmaceuticals and therapies for the treatment of major medical needs. The Company combines its patented gene transfer ...
Precision Drilling Corp (USA) NYSE PDS 8.13 +0.29 (3.70%) 2.38B
Precision Drilling Corporation (Precision) is a provider of contract drilling and completion and production services primarily to oil and natural gas ...
Executive:
Gene C. Stahl
Precision Drilling Corporation TSE PD 9.15 +0.30 (3.39%) 2.68B
Precision Drilling Corporation (Precision) is a provider of contract drilling and completion and production services primarily to oil and natural gas ...
Executive:
Gene C. Stahl
Applied Micro Circuits Corporation NASDAQ AMCC 6.03 +0.23 (3.88%) 474.74M
The Company's products include the X-Gene ARM 64 bit Server on a Chip solution, along with the X-WeaveTM family of connectivity products, ...
Qiagen NV ETR QIA 19.03 +0.13 (0.69%) 4.57B
QIAGEN NV, (QIAGEN) is a holding company, which provides sample and assay technologies. The consumable products such as sample and assay kits and automated ...
Qiagen NV FRA QIA 19.06 +0.19 (1.00%) 4.58B
QIAGEN NV, (QIAGEN) is a holding company, which provides sample and assay technologies. The consumable products such as sample and assay kits and automated ...
Assurant, Inc. NYSE AIZ 68.69 +0.72 (1.06%) 4.83B
Assurant, Inc. (Assurant) is a provider of specialized insurance products and related services in North America and select worldwide markets.
Executive:
Gene E. Mergelmeyer
Critical Outcome Technologies Inc. CVE COT 0.250 +0.010 (4.17%) 27.72M
Critical Outcome Technologies Inc. (COTI) is a biotechnology company focused on applying its computer-based technology, CHEMSAS, to identify, profile, ...
Executive:
Gene Kelly
Mutual Fund Symbol Nav Nav change
American Beacon Small Cap Value Fund Class Institutional AVFIX 27.99 +0.05 (0.18%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Investor Class AVPAX 27.13 +0.04 (0.15%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund Investor Class AAEPX 11.99 +0.22 (1.87%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund Class AMR AAMRX 12.32 +0.23 (1.90%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund Class A AEMAX 11.99 +0.22 (1.87%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Advisor Class AASSX 26.87 +0.05 (0.19%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Class Y ABSYX 27.71 +0.05 (0.18%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Class A ABSAX 26.80 +0.04 (0.15%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Class AMR AASVX 27.94 +0.05 (0.18%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund Class Institutional AEMFX 12.21 +0.22 (1.83%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund C Class AEMCX 11.86 +0.22 (1.89%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Emerging Markets Fund Class Y ACEYX 12.27 +0.23 (1.91%)
The investment seeks long-term capital appreciation. Under normal circumstances, at least 80% of the fund's net assets (plus the amount of any borrowings ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund Class R ASCVX 26.35 +0.04 (0.15%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.
American Beacon Small Cap Value Fund C Class ASVCX 26.21 +0.05 (0.19%)
The investment seeks long-term capital appreciation and current income. Under normal circumstances, at least 80% of the fund's net assets (plus the amount ...
Executive:
Gene L. Needles Jr.